Renaissance Capital logo

Biotech Cardica lowers range

February 1, 2006

Cardica, a designer and manufacturer of an automated anastomotic device to perform coronary artery bypass surgery, cut its range to $10 to $12 from $12 to $14 Wednesday evening. The offering size remains the same at 3.5 million shares. A.G. Edwards and Allen & Company are the lead managers on the deal. Timing is set for tonight.